BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22599)

  • 1. A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+--Mg2+ ATPase in defined lipid environments.
    Houslay MD
    J Pharm Pharmacol; 1977 Nov; 29(11):664-9. PubMed ID: 22599
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria.
    Egashira T; Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579
    [No Abstract]   [Full Text] [Related]  

  • 3. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoamine oxidase type B and the function of Ca2+, Mg2+-dependent adenosine triphosphatase of preparations of sarcoplasmic reticulum vesicles].
    Tat'ianenko LV; Raĭkhman LM; Gorkin VZ
    Biull Eksp Biol Med; 1977 Mar; 83(3):283-4. PubMed ID: 139953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reaction of bovine and rat liver monoamine oxidase with [14C]-clorgyline and [14C]-deprenyl.
    Salach JI; Detmer K; Youdim MB
    Mol Pharmacol; 1979 Jul; 16(1):234-41. PubMed ID: 481419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transformation of mitochondrial monoaminoxidases types A and B].
    Shatemirova KK; Vervkina IV; Gorkin VZ
    Biull Eksp Biol Med; 1977 Jun; 83(6):669-70. PubMed ID: 884293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic rates of monoamine oxidase in rat liver after clorglyine or deprenyl administration.
    Egashira T; Kamijo K
    Jpn J Pharmacol; 1979 Aug; 29(4):677-80. PubMed ID: 119888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
    Braestrup C; Andersen H; Randrup A
    Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the inhibition of rat liver monoamine oxidase by clorgyline.
    Lyles GA; Greenawalt JW
    Biochem Pharmacol; 1977 Dec; 26(23):2269-74. PubMed ID: 588309
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of selective MAO inhibitors on the conditioned avoidance response of Wistar rats.
    Knoll B; Held G; Gyarmati Z
    Pol J Pharmacol Pharm; 1977; 29(3):291-6. PubMed ID: 887504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of selective monoamine oxidase inhibitors, clorgyline and deprenyl, upon tissue glycogen stores and blood glucose levels.
    Ismahan G; Parvez H; Parvez S; Youdim MB
    J Neural Transm Suppl; 1978; (14):143-52. PubMed ID: 290735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.